BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AUA Newsroom - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AUA Newsroom
X-ORIGINAL-URL:https://newsroom.aua.am
X-WR-CALDESC:Events for AUA Newsroom
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Yerevan
BEGIN:STANDARD
TZOFFSETFROM:+0400
TZOFFSETTO:+0400
TZNAME:+04
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Asia/Yerevan:20210811T120000
DTEND;TZID=Asia/Yerevan:20210811T130000
DTSTAMP:20260617T110750
CREATED:20210809T082445Z
LAST-MODIFIED:20210809T082445Z
UID:42899-1628683200-1628686800@newsroom.aua.am
SUMMARY:Challenges and Opportunities in Drug Development: Interdisciplinary Collaboration in Innovation
DESCRIPTION:About the Event: \nDr. Ulf Hannelius will present advantages of interdisciplinary collaboration using tools from data sciences\, artificial intelligence\, and business administration\, with a focus on developing new drugs that can offer solutions to complex health problems and making them available for use. \nAbout the Speaker: \nUlf Hannelius earned his PhD in Molecular Biology from the Karolinska Institute in Stockholm where he also conducted his post-doctoral research in cancer genomics. He received an Executive MBA degree from Stockholm School of Economics. Dr. Hannelius has had experience in business development in the biotech and medtech industries prior to joining Diamyd Medical in 2015 where he has served as the CEO since 2016.    \nLanguage: English
URL:https://newsroom.aua.am/event/challenges-and-opportunities-in-drug-development-interdisciplinary-collaboration-in-innovation/
CATEGORIES:Events Calendar,Health Sciences
ATTACH;FMTTYPE=image/png:https://newsroom.aua.am/wp-content/uploads/2021/08/CTHS_ULF_Hannelius.webp
END:VEVENT
END:VCALENDAR